Hepatitis B Virus (HBV) Therapeutics - Current and Future Players Summary GlobalData has released its pharma report, "Hepatitis B Virus (HBV) Therapeutics - Current and Future Players". The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing HBV Market. The report identifies and analyses the key companies shaping and driving the global HBV market. The report provides insight into the competitive HBV landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalData's team of industry experts. *This is an on-demand report and will be delivered within 24 hrs. (excluding weekends) of the purchase. Scope - Investigation of current and future market competition for HBV - Competitor assessment - Coverage of key market players and company profiles including business description, financial overview and SWOT analysis. - Strategic assessment of HBV sector through market impact analysis, future market scenario and company analysis Reasons To Buy - Gain a high level view of the trends shaping and driving HBV market - Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition. - Create an effective counter-strategy to gain a competitive advantage against those currently in the market - What's the next big thing in the global HBV market landscape? Identify, - Understand and capitalize
Table of Contents
1.1 List of Tables 1.2 List of Figures 2 Introduction 2.1 Catalyst 2.2 Related Reports 2.3 Upcoming Related Reports 3 Market Outlook 3.1 Global Markets 3.1.1 Forecast 3.1.2 Drivers and Barriers - Global Issues 4 Current and Future Players 4.1 Overview 4.2 Trends in Corporate Strategy 4.3 Company Profiles 4.3.1 Gilead 4.3.2 Bristol-Myers Squibb 4.3.3 Roche 4.3.4 Merck 4.3.5 GSK 4.3.6 Novartis 4.3.7 Arrowhead Research 4.3.8 GlobeImmune 5 Appendix 5.1 Bibliography 5.2 Abbreviations 5.3 Methodology 5.4 Forecasting Methodology 5.4.1 Total Prevalent Cases of Chronic Hepatitis B 5.4.2 Diagnosed Chronic Hepatitis B Patients 5.4.3 Percent Drug-Treated Chronic Hepatitis B Patients 5.4.4 Drugs Included in Each Therapeutic Class 5.4.5 Launch and Patent Expiry Dates 5.4.6 General Pricing Assumptions 5.4.7 Individual Drug Assumptions 5.4.8 Generic Erosion 5.4.9 Pricing of Pipeline Agents 5.5 Primary Research - KOLs Interviewed for this Report 5.6 Primary Research - Prescriber Survey 5.7 About the Authors 5.7.1 Analyst 5.7.2 Therapy Area Director 5.7.3 Epidemiologists 5.7.4 Global Director of Therapy Analysis and Epidemiology 5.7.5 Global Head of Healthcare 5.8 About GlobalData 5.9 Disclaimer
List of Tables
Table 1: Global Sales Forecasts ($m) for Chronic Hepatitis B Therapeutics, 2014-2024 Table 2: Chronic Hepatitis B Therapeutics Market - Drivers and Barriers, 2014-2024 Table 3: Key Companies in the Chronic Hepatitis B Therapeutics Market, 8MM, 2015 Table 4: Gilead's Chronic Hepatitis B Portfolio Assessment, 2015 Table 5: BMS's Chronic Hepatitis B Portfolio Assessment, 2015 Table 6: Roche's Chronic Hepatitis B Portfolio Assessment, 2015 Table 7: Merck's Chronic Hepatitis B Portfolio Assessment, 2015 Table 8: GSK's Chronic Hepatitis B Portfolio Assessment, 2015 Table 9: Novartis' Chronic Hepatitis B Portfolio Assessment, 2015 Table 10: Arrowhead's Chronic Hepatitis B Portfolio Assessment, 2015 Table 11: GlobeImmune's Chronic Hepatitis B Portfolio Assessment, 2015 Table 12: Key Historical and Projected Launch Dates Table 13: Key Historical and Projected Patent Expiry Dates Table 14: High-Prescribing Physicians (Non-KOLs) Surveyed, By Country
List of Figures
Figure 1: Sales for Chronic Hepatitis B Therapeutics by Country, 2014-2024 Figure 2: Sales for Chronic Hepatitis B Therapeutics by Therapy Class, 2014-2024 Figure 3: Company Portfolio Gap Analysis in the Chronic Hepatitis B Therapeutic Market, 2014-2024
Global non halogenated flame retardants market size is anticipated to be valued at USD 2.54 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing safety materials demand owing to low heat & smoke emission properties in cRead More...
Global gold nanoparticles market size is expected to reach 4.99 billion by 2020, witnessing gains at a CAGR of 24.7%. Positive outlook towards the increasing applications of nanotechnology in medical and dentistry such as drug delivery systems, nanomRead More...
Global electric water heaters market is expected to be valued at USD 29,322.4 million by 2022, as per a new research report by Radiant Insights, Inc. Escalating demand across extensive range of domestic applications is expected to drive demand. EvolvRead More...
Global LCP (Liquid Crystal Polymer) industry is forecasted to reach USD 1.23 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing trend towards developing militarized components and connectors are likely to drive the demandRead More...
Global aquafeed market size is anticipated to be valued at USD 165.04 billion by 2022, as per a new research report by Radiant Insights, Inc. Increase in fish consumption for direct and indirect consumer applications is anticipated to drive the markeRead More...
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.